Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John V. Gahagan is active.

Publication


Featured researches published by John V. Gahagan.


Journal of The American College of Surgeons | 2017

Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter?

John V. Gahagan; Matthew D. Whealon; Michael J. Phelan; Steven Mills; Alessio Pigazzi; Michael J. Stamos; Ninh T. Nguyen; Joseph C. Carmichael

BACKGROUND The management algorithm for appendiceal adenocarcinoma is not well defined. This study sought to determine whether tumor size or depth of invasion better correlates with the presence of lymph node metastases in appendiceal adenocarcinoma, and to compare these rates with colon adenocarcinoma. STUDY DESIGN A retrospective review of the National Cancer Database was performed to identify patients with appendiceal or colonic adenocarcinoma from 2004 to 2013 who underwent surgical resection. Cases were categorized by tumor size and by T stage. Rates of lymph node metastases were examined as a function of size and T stage. RESULTS A total of 3,402 appendiceal and 314,864 colonic cases were identified. For appendiceal adenocarcinoma, larger tumor size was associated with higher T stage: Pearson correlation of 0.41 (95% CI 0.408 to 0.414; p < 0.001). Lymph node metastases were present in 19.1%, 27.8%, 39.6%, 39.4%, 42.4% and 39.1% for tumor sizes <1 cm, >1 to 2 cm, >2 to 3 cm, >3 to 4 cm, >4 to 5 cm, and >5 cm, respectively. Lymph node metastases were present in 0%, 11.2%, 12.3%, 35.5%, and 40.0% for in situ, T1, T2, T3, and T4 tumors, respectively. There was no difference in the rates of lymph node metastases between appendiceal and colonic adenocarcinoma for tumor sizes <3 cm, or for in situ and T1 tumors. Rates of lymph node metastases are higher in colonic adenocarcinoma for tumor sizes >3 cm and for T2, T3, and T4 tumors (p < 0.01). CONCLUSIONS In appendiceal adenocarcinoma, the rate of lymph node metastases is substantial, even for small tumors. Tumor size should play no role in the decision of whether to perform a hemicolectomy. Appendectomy alone does not produce an adequate lymph node sample. Right hemicolectomy should be performed for all appendiceal adenocarcinomas.


Annals of Surgery | 2017

Defining the Role of Minimally Invasive Proctectomy for Locally Advanced Rectal Adenocarcinoma

Sarath Sujatha-Bhaskar; Mehraneh D. Jafari; John V. Gahagan; Colette S. Inaba; Christina Y. Koh; Steven Mills; Joseph C. Carmichael; Michael J. Stamos; Alessio Pigazzi

Objective: National examination of open proctectomy (OP), laparoscopic proctectomy (LP), and robotic proctectomy (RP) in pathological outcomes and overall survival (OS). Background: Surgical management for rectal adenocarcinoma is evolving towards utilization of LP and RP. However, the oncological impacts of a minimally invasive approach to rectal cancer have yet to be defined. Methods: Retrospective review of the National Cancer Database identified patients with nonmetastatic locally advanced rectal adenocarcinoma from 2010 to 2014, who underwent neoadjuvant chemoradiation, surgical resection, and adjuvant therapy. Cases were stratified by surgical approach. Multivariate analysis was used to compare pathological outcomes. Cox proportional-hazard modeling and Kaplan–Meier analyses were used to estimate long-term OS. Results: Of 6313 cases identified, 53.8% underwent OP, 31.8% underwent LP, and 14.3% underwent RP. Higher-volume academic/research and comprehensive community centers combined to perform 80% of laparoscopic cases and 83% of robotic cases. In an intent-to-treat model, multivariate analysis demonstrated superior circumferential margin negativity rates with LP compared with OP (odds ratio 1.34, 95% confidence interval 1.02–1.77, P = 0.036). Cox proportional-hazard modeling demonstrated a lower death hazard ratio for LP compared with OP (hazard ratio 0.81, 95% confidence interval 0.67–0.99, P = 0.037). Kaplan–Meier analysis demonstrated a 5-year OS of 81% in LP compared with 78% in RP and 76% in OP (P = 0.0198). Conclusion: In the hands of experienced colorectal specialists treating selected patients, LP may be a valuable operative technique that is associated with oncological benefits. Further exploration of pathological outcomes and long-term survival by means of prospective randomized trials may offer more definitive conclusions regarding comparisons of open and minimally invasive technique.


Journal of Gastroenterology, Pancreatology & Liver Disorders | 2018

An Analysis of Risk Factors, Timing of Complications and Readmission after Pancreaticoduodenectomy

John V. Gahagan; Mark H. Hanna; Zhobin Moghadamyeghaneh; Reza Fazl Alizadeh; Adrienne Nguyen; Maki Yamamoto; Michael J. Stamos; Aram N. Demirjian; David K. Imagawa

The first successful pancreaticoduodenectomy (PD) was performed and reported by Whipple, Parsons and Mullins in 1935[1]. The authors reported a case series of three patients who underwent a two stage procedure for the treatment of ampullary carcinoma. A one-stage PD was later reported by Trimble in 1941. During the early stages of this procedure, morbidity and mortality were exceedingly high, up to 50% and 30%, respectively [2-4].


Surgical Endoscopy and Other Interventional Techniques | 2017

Volume and outcomes relationship in laparoscopic diaphragmatic hernia repair

Matthew D. Whealon; Juan J. Blondet; John V. Gahagan; Michael J. Phelan; Ninh T. Nguyen

BackgroundThere is no published data regarding the relationship between hospital volume and outcomes in patients undergoing laparoscopic diaphragmatic hernia repair. We hypothesize that hospitals performing high case volume have improved outcomes compared to low-volume hospitals.Materials and methodsWe reviewed the National Inpatient Sample (NIS) database between 2008 and 2012 for adults with the diagnosis of diaphragmatic hernia who underwent elective laparoscopic repair of diaphragmatic Hernia and/or Nissen fundoplication. Pediatric, emergent, and open cases were excluded. Main outcome measures included logistic regression analysis of factors predictive of in-hospital mortality and outcomes according to annual hospital case volume.ResultsA total of 31,228 laparoscopic diaphragmatic hernia operations were analyzed. The overall in-hospital mortality was 0.14%. Risk factors for higher in-hospital mortality included renal failure (AOR: 6.26; 95% CI: 2.48–15.78; p < 0.001), age>60 years (AOR: 5.06; 95% CI: 2.38–10.76; p < 0.001), and CHF (AOR: 3.80; 95% CI: 1.39–10.38; p = 0.009) while an incremental increase in volume of 10 cases/year (AOR: 0.89; 95% CI: 0.81–0.98; p = 0.019) and diabetes (AOR: 0.34; 95% CI: 0.12–0.93; p = 0.036) decreases mortality. There was a small but significant inverse relationship between hospital case volume and mortality with a 10% reduction in adjusted odds of in-hospital mortality for every increase in 10 cases per year. Using 10 cases per year as the volume threshold, low-volume hospitals (≤10 cases/year) had almost a twofold higher mortality compared to high-volume hospitals (0.23 vs. 0.12%, respectively, p = 0.02).ConclusionsThere was a small but significant inverse relationship between the hospitals’ case volume and mortality in laparoscopic diaphragmatic hernia repair.


Archive | 2017

Robotic Abdominoperineal Resection

Grace S. Hwang; John V. Gahagan; Alessio Pigazzi

Minimally invasive approaches to colorectal disease and cancer have been largely accepted and new techniques are being explored on several fronts. Robotic and robotic-assisted laparoscopic colorectal dissection is one such area and has become more and more relevant in this field. This approach is especially important for cases requiring precise movements in a limited space, such as in pelvic dissections. The use of the robotic technique has led to improved outcomes and lower rates of conversion and, in some areas, reduced morbidity. In this chapter, we will review our operative techniques of robotic-assisted abdominoperineal resection (APR).


Annals of Surgical Oncology | 2017

Erratum to: Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Matthew D. Whealon; John V. Gahagan; Sarath Sujatha-Bhaskar; Michael P. O’Leary; Matthew J. Selleck; Sinziana Dumitra; Byrne Lee; Maheswari Senthil; Alessio Pigazzi

Background The role of fecal diversion with pelvic anastomosis during cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is not well defined.


Journal of endourology case reports | 2016

Hand-Assisted Laparoscopic Donor Nephrectomy in Complete Situs Inversus

John V. Gahagan; Matthew D. Whealon; Uttam Reddy; Clarence E. Foster; Hirohito Ichii

Abstract Complete situs inversus is a rare congenital anomaly characterized by transposition of organs. We report a case of renal transplantation using a kidney from a living complete situs inversus donor. The recipient was a 59-year-old female with end-stage renal disease because of type 2 diabetes mellitus. The donor was the 56-year-old sister of the recipient with complete situs inversus. CT angiogram of the abdomen and pelvis showed complete situs inversus and an otherwise normal appearance of the bilateral kidneys with patent bilateral single renal arteries and longer renal vein in the right kidney. The patient was taken to the operating room for a hand-assisted laparoscopic right donor nephrectomy. The patient tolerated the procedure well and was discharged home in good condition on postoperative day 1. The recipient experienced no episodes of acute rejection or infection, with serum creatinine levels of 0.8–1.2 mg/dL. Laparoscopic donor nephrectomy in a patient with complete situs inversus remains a technically feasible operation and the presence of situs inversus should not preclude consideration for living kidney donation.


Journal of Gastrointestinal Surgery | 2016

Colorectal Surgery in Patients with HIV and AIDS: Trends and Outcomes over a 10-Year Period in the USA.

John V. Gahagan; Wissam J. Halabi; Vinh Q. Nguyen; Joseph C. Carmichael; Alessio Pigazzi; Michael J. Stamos; Steven Mills


Journal of The American College of Surgeons | 2018

Margins Matter: Furthering the Case for Neoadjuvant Therapy in Resectable Pancreatic Adenocarcinoma

John V. Gahagan; Matthew D. Whealon; David K. Imagawa; Aram N. Demirjian


Seminars in Colon and Rectal Surgery | 2016

Robotic low anterior resection

John V. Gahagan; Alessio Pigazzi

Collaboration


Dive into the John V. Gahagan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Steven Mills

University of California

View shared research outputs
Top Co-Authors

Avatar

Ninh T. Nguyen

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge